NEW YORK (GenomeWeb) – In an analysis published in Nature Medicine today, the Broad Institute's David Scott and Feng Zhang said that prescreening patients with whole-genome sequencing and then integrating that information with empirical methods for guiding RNA selection could help researchers design CRISPR-based therapeutics that are both efficacious and safe.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Sometimes genetic tests give inconclusive results and provide little reassurance to patients, the Associated Press reports.

Vox wonders whether gene-editing crops will be viewed similarly as genetically modified organisms of if people will give them a try.

In Science this week: research regulation and reporting requirement reform, and more.

With H3Africa, Charles Rotimi has been working to bolster the representation of African participants and African researchers in genomics, Newsweek reports.

Aug
07
Sponsored by
Qiagen

This webinar will present the results of an evaluation of a web-based variant interpretation software system for clinical next-generation sequencing.